Pathology: mML - L1 - all population;
| mML - L1 - all population | |||||
| CheckMate 067 (NI vs I ; all population), 2015 | CheckMate 069 (all population), 2015 | CheckMate 067 (NI vs N) EXPLORATORY, 2015 | RELATIVITY-047, 0 | ||
| nivolumab plus ipilimumab | 3 | T1 | T1 | T1 | |
| relatlimab plus nivolumab | 1 | T1 | |||
| nivolumab alone | 0 | T0 | T0 | ||
| ipilimumab alone | 0 | T0 | T0 | ||